Nasal Obstruction and Septoplasty Effectiveness - Duke University ...
Nasal Obstruction and Septoplasty Effectiveness - Duke University ...
Nasal Obstruction and Septoplasty Effectiveness - Duke University ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Nasal</strong> <strong>Obstruction</strong><br />
<strong>and</strong> <strong>Septoplasty</strong><br />
<strong>Effectiveness</strong><br />
NOSE<br />
Reason for Study<br />
The NOSE Study is designed to evaluate the effectiveness <strong>and</strong><br />
quality of life associated with surgical treatment of chronic nasal<br />
obstruction due to septal deviation in adult patients.<br />
<strong>Septoplasty</strong> is the third most commonly performed<br />
surgical procedure in the United States. The procedure<br />
is designed to alleviate symptoms of nasal<br />
obstruction in patients with a deviated septum.<br />
Sponsored by National Center for the Promotion of<br />
Research in Otolaryngology (NCPRO), the NOSE<br />
study is the only known prospective cohort study, to<br />
date, which uses an outcomes instrument specifically<br />
designed to examine the disease-specific quality of<br />
life associated with nasal obstruction.<br />
Specific Study Aims<br />
To develop<br />
To utilize<br />
To assess<br />
<strong>and</strong> validate a disease-specific outcomes<br />
instrument for nasal obstruction<br />
the instrument to examine the effectiveness<br />
of nasal septoplasty with or without<br />
turbinate reduction in relieving symptoms<br />
<strong>and</strong> secondary effects of nasal obstruction<br />
at three <strong>and</strong> six months after surgery<br />
patient satisfaction with the results of their<br />
surgery<br />
The study aims to develop <strong>and</strong> validate a disease-specific<br />
outcomes instrument for nasal obstruction; <strong>and</strong> to use this<br />
instrument to examine the effectiveness of nasal septoplasty with<br />
or without turbinate reduction in relieving the symptoms <strong>and</strong><br />
secondary effects of nasal obstruction, with follow-up at three<strong>and</strong><br />
six months after surgery.<br />
For Results about the NOSE Study<br />
http://www.entnet.org/research<br />
Study Contact Information Site Coordinator<br />
Tanya Darrow, BS<br />
<strong>Duke</strong> Medical Center<br />
darro004@mc.duke.edu<br />
Phone: 919-668-8222<br />
Fax: 919-668-7106<br />
NOSE Steering Committee<br />
Michael G. Stewart, MD, MPH<br />
Principal Investigator<br />
Baylor College of Medicine<br />
mgstew@bcm.tmc.edu<br />
Maureen Hannley, PhD<br />
Chief Research Officer<br />
American Academy of Otolaryngology—<br />
Head <strong>and</strong> Neck Surgery Foundation<br />
mhannley@entnet.org<br />
Timothy L. Smith, MD, MPH<br />
Medical College of Wisconsin<br />
Edward M. Weaver, MD, MPH<br />
<strong>University</strong> of Washington<br />
David L. Witsell, MD, MHS<br />
<strong>Duke</strong> <strong>University</strong> Medical Center<br />
Bevan Yueh, MD, MPH<br />
<strong>University</strong> of Washington<br />
P. Ashley Wackym, MD<br />
Medical College of Wisconsin